Corrigendum: Hypertension and the risk of endometrial cancer: A systematic review and metaanalysis of case-control and cohort studies (Scientific Reports DOI: 10.1038/srep44808);Hypertension and the risk of endometrial cancer: A systematic review and meta-analysis of case-control and cohort studies

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Aune, Dagfinn ^a,b,c   Sen, Abhijit ^a   Vatten, Lars J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c BJØRKNES UNIVERSITY COLLEGE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85017198786     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46961     Document Type: Erratum

References (67)

1. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (2002).
2. Lewington, S. et al. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern. Med. 176, 524-532 (2016).
3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117-171 (2015).
4. Field, A. E. et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch. Intern. Med. 161, 1581-1586 (2001).
5. Hernelahti, M., Kujala, U. & Kaprio, J. Stability and change of volume and intensity of physical activity as predictors of hypertension. Scand. J. Public Health 32, 303-309 (2004).
6. Williams, P. T. A cohort study of incident hypertension in relation to changes in vigorous physical activity in men and women. J. Hypertens. 26, 1085-1093 (2008).
7. Okubo, Y. et al. Association of alcohol consumption with incident hypertension among middle-aged and older Japanese population: the Ibarakai Prefectural Health Study (IPHS). Hypertension 63, 41-47 (2014).
8. Wang, L., Manson, J. E., Buring, J. E. & Sesso, H. D. Meat intake and the risk of hypertension in middle-aged and older women. J. Hypertens. 26, 215-222 (2008).
9. Wang, L., Manson, J. E., Gaziano, J. M., Buring, J. E. & Sesso, H. D. Fruit and vegetable intake and the risk of hypertension in middleaged and older women. Am. J. Hypertens. 25, 180-189 (2012).
10. Wang, L. et al. Whole-and refined-grain intakes and the risk of hypertension in women. Am. J. Clin. Nutr. 86, 472-479 (2007).
11. He, F. J., Li, J. & MacGregor, G. A. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst. Rev. 4, CD004937 (2013).
12. Forman, J. P., Stampfer, M. J. & Curhan, G. C. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 46, 500-507 (2005).
13. Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108 (2015).
14. Matsuda, T. et al. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J Clin Oncol. 41, 139-147 (2011).
15. Huang, C. Y. et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PLoS One 7, e51372 (2012).
16. Aune, D. et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann. Oncol. 26, 1635-1648 (2015).
17. Cust, A. E., Armstrong, B. K., Friedenreich, C. M., Slimani, N. & Bauman, A. Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control 18, 243-258 (2007).
18. Friberg, E., Orsini, N., Mantzoros, C. S. & Wolk, A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia (2007).
19. Bernstein, L. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin. Pharmacol. Toxicol. 98, 288-296 (2006).
20. Elwood, J. M., Cole, P., Rothman, K. J. & Kaplan, S. D. Epidemiology of endometrial cancer. J. Natl. Cancer Inst. 59, 1055-1060 (1977).
21. Austin, H., Austin, J. M. Jr., Partridge, E. E., Hatch, K. D. & Shingleton, H. M. Endometrial cancer, obesity, and body fat distribution. Cancer Res. 51, 568-572 (1991).
22. Inoue, M. et al. A case-control study on risk factors for uterine endometrial cancer in Japan. Jpn. J. Cancer Res. 85, 346-350 (1994).
23. Goodman, M. T. et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res. 57, 5077-5085 (1997).
24. Soler, M. et al. Hypertension and hormone-related neoplasms in women. Hypertension 34, 320-325 (1999).
25. McCann, S. E. et al. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control 11, 965-974 (2000).
26. Salazar-Martinez, E. et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11, 707-711 (2000).
27. Weiderpass, E. et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11, 185-192 (2000).
28. Strom, B. L. et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am. J. Epidemiol. 164, 775-786 (2006).
29. Weiss, J. M. et al. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am. J. Epidemiol. 164, 56-62 (2006).
30. Soliman, P. T. et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106, 2376-2381 (2006).
31. Fortuny, J. et al. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol. Biomarkers Prev. 18, 1448-1456 (2009).
32. Reis, N. & Beji, N. K. Risk factors for endometrial cancer in Turkish women: results from a hospital-based case-control study. Eur. J. Oncol. Nurs. 13, 122-127 (2009).
33. Zhang, Y. et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol. Oncol. 117, 41-46 (2010).
34. Friedenreich, C. M. et al. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 20, 2384-2395 (2011).
35. Rosato, V. et al. Metabolic syndrome and endometrial cancer risk. Ann. Oncol. 22, 884-889 (2011).
36. Trabert, B. et al. Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol. Biomarkers Prev. 24, 261-267 (2015).
37. Shao, Y. et al. Insulin is an important risk factor of endometrial cancer among premenopausal women: a case-control study in China. Tumour. Biol. (2015).
38. La Vecchia, C., Decarli, A., Fasoli, M. & Gentile, A. Nutrition and diet in the etiology of endometrial cancer. Cancer 57, 1248-1253 (1986).
39. Mack, T. M. et al. Estrogens and endometrial cancer in a retirement community. N. Engl. J Med. 294, 1262-1267 (1976).
40. Tulinius, H., Sigfusson, N., Sigvaldason, H., Bjarnadottir, K. & Tryggvadottir, L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol. Biomarkers Prev. 6, 863-873 (1997).
41. Folsom, A. R., Demissie, Z. & Harnack, L. Glycemic index, glycemic load, and incidence of endometrial cancer: the Iowa women's health study. Nutr. Cancer 46, 119-124 (2003).
42. Furberg, A. S. & Thune, I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int. J Cancer 104, 669-676 (2003).
43. Ollberding, N. J. et al. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl. Cancer Inst. 104, 67-76 (2012).
44. Sponholtz, T. R. et al. Body Size, Metabolic Factors, and Risk of Endometrial Cancer in Black Women. Am. J. Epidemiol. 183, 259-268 (2016).
45. Gelber, R. P., Gaziano, J. M., Manson, J. E., Buring, J. E. & Sesso, H. D. A prospective study of body mass index and the risk of developing hypertension in men. Am. J. Hypertens. 20, 370-377 (2007).
46. Rossi, R., Turco, V., Origliani, G. & Modena, M. G. Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women. J. Hypertens. 24, 2017-2022 (2006).
47. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009).
48. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177-188 (1986).
49. Hamling, J., Lee, P., Weitkunat, R. & Ambuhl, M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat. Med. 27, 954-970 (2008).
50. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
51. Egger, M., Davey, S. G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).
52. Begg, C. B. & Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101 (1994).
53. Wells, G. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www. ohri.ca/programs/clinical-epidemiology/oxford.asp, Accessed 13.08.2014.
54. Bjorge, T. et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol. 171, 892-902 (2010).
55. Cust, A. E. et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat Cancer 14, 755-767 (2007).
56. Settnes, A. & Jorgensen, T. Hypertension and hysterectomy in Danish women. Obstet. Gynecol. 92, 274-280 (1998).
57. Settnes, A., Andreasen, A. H. & Jorgensen, T. Hypertension is associated with an increased risk for hysterectomy: a Danish cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 218-224 (2005).
58. Radin, R. G. et al. Hypertension and risk of uterine leiomyomata in US black women. Hum. Reprod. 27, 1504-1509 (2012).
59. Benshushan, A., Paltiel, O., Rojansky, N., Brzezinski, A. & Laufer, N. IUD use and the risk of endometrial cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 105, 166-169 (2002).
60. Dumesic, D. A. & Lobo, R. A. Cancer risk and PCOS. Steroids 78, 782-785 (2013).
61. Hamet, P. Cancer and hypertension: a potential for crosstalk? J. Hypertens. 15, 1573-1577 (1997).
62. Bangalore, S. et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 12, 65-82 (2011).
63. Pasternak, B., Svanstrom, H., Callreus, T., Melbye, M. & Hviid, A. Use of angiotensin receptor blockers and the risk of cancer. Circulation 123, 1729-1736 (2011).
64. Behrens, I. et al. Hypertensive disorders of pregnancy and subsequent risk of solid cancer - A nationwide cohort study. Int. J. Cancer 139, 58-64 (2016).
65. Hallum, S., Pinborg, A. & Kamper-Jorgensen, M. Long-term impact of preeclampsia on maternal endometrial cancer risk. Br. J. Cancer 114, 809-812 (2016).
66. Havulinna, A. S. et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 61, 987-994 (2013).
67. Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151-1161 (2016).